Tonghua Dongbao Pharmaceutical Co.Ltd(600867) 418 announced that in 2021, the company achieved an operating revenue of 3.267 billion yuan, with a year-on-year increase of 12.99%; The net profit attributable to the shareholders of the listed company was 1.308 billion yuan, a year-on-year increase of 40.69%; Distribute a cash dividend of 3 yuan for every 10 shares to all shareholders.